300 likes | 537 Views
Beta Amyloid and Nitric Oxide : Putative Links. Umesh Chaudhary. Contents. Introduction. Nitric oxide and neurological functioning. Molecular basis of Alzheimer’s disease. B-Amyloid stimulation of iNOS : TNF alpha and NF-kB dependent iNOS expression.
E N D
Beta Amyloid and Nitric Oxide : Putative Links Umesh Chaudhary
Contents • Introduction • Nitric oxide and neurological functioning • Molecular basis of Alzheimer’s disease • B-Amyloid stimulation of iNOS : • TNF alpha and NF-kB dependent iNOS expression. • Current prospects in Alzheimer therapy
Nitric Oxide A class of inter- and intra-cellular messenger molecules • Small molecular weight, Highly diffusible, Gaseous, Highly reactive stable free radical • Second messenger role requires • low concentrations of NO (<2mM) • occurs usually via guanylate cyclase. • Cytotoxic effects due to a combination of • Elevated concentration (>10mM) • Formation of highly reactive peroxynitrite
Chemistry of Indirect Effects Direct Effects of Nitric Oxide Free Radical Biology & Medicine, Vol. 25, Nos. 4/5, pp. 434–456, 1998
Nitric Oxide Biosynthesis Overall reaction Catalyzed and cofactors of NOS Biochem. J. (2001) 357, 593-615
Nitric Oxide and Nervous System • Extensive distribution of NOS positive neuron • Role in long term potentiation • Learning and Memory • Pain perception • Neuromodulatory functions • Host defense against pathogens • Neurotoxicity
Alzheimer’s Disease • Epidemiology • Most common Neurodegenerative disorder & dementia • Currently affecting nearly 5 million individuals in USA alone. • Symptoms • Progressive cognitive decline affecting memory, learning, emotions and behaviour • Pathology • Neurofibrillary Tangles, Senile Plaques and Synapse Loss • Mutation in one of the genes that codes for three transmembrane proteins-APP, PS1 and PS2 • APOe4 allele is higher 3
VARADARAJAN ET AL. Journal of Structural Biology 130, 184–208 (2000) Central Role of Amyloid b in Neurotoxicity
VARADARAJAN ET AL. Journal of Structural Biology 130, 184–208 (2000) Amyloid Precursor Protein Processing • APP is 770AA Transmembrane protein, Gene located on Chromosome 21 • Cleavage by a,b and g Secretase yields Amyloid b ( 1-40, 42) • Conversion of soluble forms to insoluble fibrils accounts for its toxicity • Amyloid b binding to RAGE leads to formation of plaque • Amyloid can directly produce Hydrogen peroxide through metal ion reduction
Mutations in Presenilin genes • Presenilin 1 (PS1) on chromo 14 encodes 467 residue polypeptide & Presenilin 2 (PS2) on chromo 1 encodes for 448 residue polypeptide • PS1 and PS2 are found in nuclear membrane ,ER and Golgi body • Necessary for Neurogenesis and Neuronal survival • 50 mutations of PS1 and 2 mutations of PS2 found in AD families Apolipoprotein E • A plasma protein Involved in transport and metabolism of triglyceride and cholesterol • e2, e3 and e4 allelic variants • ApoE e4 allelic variant is high and linked with Alzheimer All mutations enhances production of Fibrillar A b 42 and Tau Hyper-phosphorylation leading to NFT’s
p p p p p p p p p P sites -C N- Microtubule binding domain (MBD) Neurofibrillary Tangles • Intra neuronal lesions in degenerating neurones • Composed of hyper-phosphorylated tau-protein organised in paired helical filaments Tau is a soluble, microtubule-associated phospho-protein involved in neuronal stabilisation • In AD Tau becomes hyper-phosphorylated
NO Neurotoxicity and Neuroprotection in AD Law et al . / Brain Research Reviews 35 (2001) 73– 96
b -Amyloid Stimulation of Inducible Nitric-oxide Synthase in Astrocytes Is Interleukin-1b- and Tumor Necrosis Factor-a (TNFa)-dependent, and Involves a TNFa Receptor-associated Factor- and NFkB-inducing Kinase-dependent Signaling Mechanism (Keith T. Akama and Linda J. Van Eldik) From the ‡Department of Cell and Molecular Biology and §Northwestern Drug Discovery Program, NorthwesternUniversity Medical School, Chicago, Illinois 60611 The Journal of Biological Chemistry, Vol-275. No. 11, March 17, pp –7918-7924
A- b stimulated Cytokine production occurs before iNOS Production
Protein synthesis inhibitor blocks A b stimulated iNOS mRNA levels
IL-1 b Receptor antagonist Decreases the levels of Amyloid b-stimulated i-NOS and Nitrite Production
Dominant Negative TRAF Proteins can Block NF-kB Activation in Astrocytes
Dominant Negative TRAF6 Inhibits iNOS Promoter Activation by A b 42
IL-1 b Localizes to Microglia and iNOS Localizes to Astrocytes in A b 42 Stimulated Glial Cultures
SUMMARY • Amyloid b activates Microglia to produce Pro-Inflammatory Cytokines such as IL-1 b and TNF- a • These Cytokines in turn activate surrounding Astrocytes, which exacerbate the inflammation with the production of Neurotoxic Mediators such as iNOS. • The resultant NO and Peroxynitrite ultimately damages local neurons and contributes to the Neurodegeneration observed in AD
Binding to Neurotrophin receptor leads to Apoptotic cell death • Induction of Transcription of c-JUN mRNA and stimulates JUN Amino Terminal Kinase
Amyloid can Directly activate Caspase 3 and induce Apoptosis in Neurons Science Vol 293, 21 September 2001 P- 2192-94
Potential Novel Therapeutic Approach Focusing on b -Amyloid plaques • Enhance alpha-Secretase activity or inhibit beta or gamma-Secretase activity • Correcting APP or presenilin mutations • Antioxidants such as Vitamin E and Extracts from roots of Ginko biloba • Oestrogen modulate APP processing and reduce Amyloid- b 42 • Vaccination with Amyloid Beta • Focusing on Apolipoprotein E • Replace ApoE e4 alleles with e2/3 alleles • Cholesterol lowering drugs ( Lipitor ) • Tau protein based therapies • Prevent t-protein phosphorylation Gene Therapy - Nerve Growth Factor, Propentophylline 22
Conclusions • Oxidative stress plays a vital role in Alzheimer Pathology • Amyloid-b can initiate a variety of signalling cascades leading to Neuronal cell death in AD • Amyloid-b can stimulate Pro inflammatory cytokines and ultimately contribute to Oxidative and Nitrosative Stress induced cell death and Apoptosis • Further Detailed Studies needed to have a deeper Insight into Signal transduction pathways involved in Alzheimer Disease
Illness in Alzheimer's vaccine study AP [ SUNDAY, FEBRUARY 24, 2002 7:10:41 PM ] TIMES - SUNDAY, FEBRUARY 24, 2002 Twelve Alzheimer's patients injected with an experimental vaccine are suffering serious brain inflammation. The vaccine's manufacturer halted the experiment last month when it discovered that the first four patients, all from France, were suffering the encephalitis-like reaction. Since then, doctors have discovered eight more people with the apparent side effect, which can be hard to distinguish from worsening Alzheimer's.